The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
115353033 11535303 3 F 20140528 20160914 20150922 20160919 EXP US-009507513-1509USA010632 MERCK 0.00 M Y 68.27000 KG 20160919 LW US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
115353033 11535303 1 PS JANUVIA SITAGLIPTIN PHOSPHATE 1 Oral 100 MG, QD 59900 MG 21995 100 MG FILM-COATED TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
115353033 11535303 1 Type 2 diabetes mellitus

Outcome of event

Event ID CASEID OUTC COD
115353033 11535303 HO
115353033 11535303 DE
115353033 11535303 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
115353033 11535303 Acute hepatic failure
115353033 11535303 Acute kidney injury
115353033 11535303 Adenocarcinoma pancreas
115353033 11535303 Aortic valve calcification
115353033 11535303 Atelectasis
115353033 11535303 Atrial fibrillation
115353033 11535303 Bile duct obstruction
115353033 11535303 Blood calcium decreased
115353033 11535303 Blood glucose decreased
115353033 11535303 Cardiomegaly
115353033 11535303 Cholelithiasis
115353033 11535303 Chronic kidney disease
115353033 11535303 Constipation
115353033 11535303 Cystitis escherichia
115353033 11535303 Death
115353033 11535303 Duodenal ulcer
115353033 11535303 End stage renal disease
115353033 11535303 Hyperlipidaemia
115353033 11535303 Hypertension
115353033 11535303 Hypokalaemia
115353033 11535303 Hyponatraemia
115353033 11535303 Leukocytosis
115353033 11535303 Malnutrition
115353033 11535303 Metabolic acidosis
115353033 11535303 Mitral valve disease
115353033 11535303 Normochromic normocytic anaemia
115353033 11535303 Oesophageal candidiasis
115353033 11535303 Orchitis
115353033 11535303 Pulmonary hypertension
115353033 11535303 Renal tubular necrosis
115353033 11535303 Rhabdomyolysis
115353033 11535303 Tricuspid valve incompetence
115353033 11535303 Urinary tract infection fungal
115353033 11535303 Ventricular tachycardia
115353033 11535303 Vitamin D deficiency

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
115353033 11535303 1 20121008 20140529 0